Clinical Trial Update: Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for sotorasib in advanced KRASG12C-mutated non-small cell lung cancer patients with comorbidities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• sotorasib (sotorasib)

Snippet

Sponsor: Vestre Viken Hospital Trust | Conditions: Lung Cancer, NSCLC, Stage III | Phase 2 | Status: UNKNOWN